The White House withdrew Heidi Overton's nomination to head the US Food and Drug Administration (FDA), Axios reports. The regulator controls the circulation of goods, which make up about 20% of consumer spending in the United States. The decision was made due to a lack of support in the Senate before the vote in the relevant committee; Kyle Diamantas will continue to serve as interim head of the agency.